Aemetis (NASDAQ:AMTX) Rating Increased to Sell at StockNews.com

Aemetis (NASDAQ:AMTX) was upgraded by stock analysts at StockNews.com to a “sell” rating in a report issued on Wednesday.

Other equities analysts also recently issued research reports about the company. HC Wainwright restated a “buy” rating and set a $28.00 target price on shares of Aemetis in a research report on Monday. Ascendiant Capital Markets decreased their price objective on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company. According to MarketBeat, Aemetis currently has an average rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Trading Up 8.7 %

Shares of Aemetis stock opened at $2.86 on Wednesday. Aemetis has a 1 year low of $2.10 and a 1 year high of $7.03. The company’s fifty day simple moving average is $3.29 and its 200-day simple moving average is $2.99. The company has a market cap of $142.24 million, a price-to-earnings ratio of -1.27 and a beta of 1.35.

Aemetis (NASDAQ:AMTX) last released its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The firm had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same period last year, the business earned ($0.59) earnings per share. As a group, research analysts forecast that Aemetis will post -2.02 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aemetis

Several large investors have recently made changes to their positions in AMTX. Geode Capital Management LLC boosted its stake in shares of Aemetis by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after purchasing an additional 66,031 shares during the last quarter. State Street Corp increased its position in shares of Aemetis by 36.1% in the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after buying an additional 185,304 shares in the last quarter. Susquehanna Fundamental Investments LLC lifted its holdings in Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after acquiring an additional 93,536 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Aemetis in the second quarter valued at about $306,000. Finally, Wellington Management Group LLP bought a new stake in shares of Aemetis in the third quarter worth about $177,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.